Blog
A second set of cases in the ongoing Abilify Gambling Multi District Litigation have been designated for bellwether trials. Forty cases were selected at random on August 8th by Chief Judge M. Casey Rodgers in an order. The order also explains that Plaintiffs and Defendants would have 14 days to each strike five cases from…
Read More
Despite concerns about risks and dangers associated with Abilify, the product has crossed a digital milestone. Abilify MyCite is now the first digital medicine approved by the U.S. Food and Drug Administration (FDA). And while it has been approved for treatment of some conditions, the expanded applications of drug continue to raise concerns about its…
Read More
On May 3, 2016 the Food and Drug Administration (FDA) announced that the generic drug aripiprazole (Abilify, Abilify Maintena, Aristada, and generics) was found to be associated with impulsive behaviors and diminished impulse control. Following the FDA’s announcement, investigations into whether the manufacturers acted negligently began and Abilify lawsuits began being filed by the hundreds…
Read More